Dolby Medical Home Respiratory Care Limited (Vivisol) to acquire Air Liquide Healthcare Limited’s home oxygen services business

Dolby Medical Home Respiratory Care Limited, trading as Vivisol, has agreed to acquire the home oxygen services business of Air Liquide Healthcare Limited in a strategic acquisition. The transaction, announced on 11 August 2026, involves the transfer of a significant healthcare asset within the United Kingdom. Vivisol, operating from the UK, is purchasing the specific division of Air Liquide Healthcare Limited, which is also based in the UK. This move represents a consolidation of home respiratory care services under the Vivisol brand. The financial terms of the deal have not been disclosed, and no specific consideration type was reported in the available data. The sector classification for this transaction is healthcare, reflecting the nature of the home oxygen services being transferred from the incumbent provider to the acquiring entity.

The deal structure is defined as a strategic acquisition rather than a management buyout or merger of equals. Both the buyer and the target operate within the same national market, facilitating a straightforward transfer of business operations. The last reported status for the transaction is that a scheme has been proposed. This indicates that the agreement is in the early stages of formalisation. The transaction remains subject to necessary regulatory approvals and internal governance processes before completion. No completion date has been set at this time. The parties are expected to proceed with the required statutory filings to finalise the acquisition of the home oxygen services business.